Tumor Lysis Syndrome by A. Hong, K. Schlosser | OPENPediatrics
8,065
Published 2020-12-17
Initial publication: December 17, 2020.
Please visit: www.openpediatrics.org
OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user.
For further information on how to enroll, please email: [email protected]
Please note: OPENPediatrics does not support nor control any related videos in the sidebar, these are placed by Youtube. We apologize for any inconvenience this may cause.
All Comments (10)
-
OPENPediatrics thank you for breaking this down! Please continue to create more content like this.
-
love the explanation on this topic.... thank you
-
Thank you so much Dr. Hong and Open pediatrics- it was very, very well explained
-
To help prevent TLS, assess patients undergoing chemotherapy for risk factors at baseline and monitor them during and after the start of treatment as ordered. The mainstays of preventive care are hydration and allopurinol and recombinant urate oxidase (rasburicase).👍
-
Open pediatrics 👍as good as always !!
-
Amazing lecture video❤
-
I do love this!
-
Best
-
Hi. What is the best specific IV fluid for TLS? Thanks.